Eli Lilly & Co. (LLY) Sinks 11% on Solanezumab Failure
Tweet Send to a Friend
Eli Lilly & Co. (NYSE: LLY) falls 11% after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
